Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Cash from Investing Activities (2018 - 2025)

Historic Cash from Investing Activities for Precision Biosciences (DTIL) over the last 8 years, with Q3 2025 value amounting to $17000.0.

  • Precision Biosciences' Cash from Investing Activities rose 12656.25% to $17000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$406000.0, marking a year-over-year decrease of 43421.05%. This contributed to the annual value of -$215000.0 for FY2024, which is 10368.85% down from last year.
  • Latest data reveals that Precision Biosciences reported Cash from Investing Activities of $17000.0 as of Q3 2025, which was up 12656.25% from -$12000.0 recorded in Q2 2025.
  • Precision Biosciences' Cash from Investing Activities' 5-year high stood at $7.6 million during Q3 2023, with a 5-year trough of -$1.7 million in Q2 2021.
  • In the last 5 years, Precision Biosciences' Cash from Investing Activities had a median value of -$632000.0 in 2022 and averaged -$200894.7.
  • As far as peak fluctuations go, Precision Biosciences' Cash from Investing Activities surged by 79394.5% in 2023, and later crashed by 110769.23% in 2025.
  • Quarter analysis of 5 years shows Precision Biosciences' Cash from Investing Activities stood at -$1.5 million in 2021, then skyrocketed by 58.01% to -$632000.0 in 2022, then skyrocketed by 106.65% to $42000.0 in 2023, then tumbled by 330.95% to -$97000.0 in 2024, then skyrocketed by 117.53% to $17000.0 in 2025.
  • Its last three reported values are $17000.0 in Q3 2025, -$12000.0 for Q2 2025, and -$314000.0 during Q1 2025.